Supplemental Materials for "A Phase 2a Trial of Brepocitinib for Cicatricial Alopecia"
Published: 15 October 2024| Version 1 | DOI: 10.17632/nsjbw2d8r2.1
Contributors:
, , , , , , , , , , , , , , , , , Description
Supplemental material for "A phase 2a trial of brepocitinib for cicatricial alopecia"
Files
Institutions
Icahn School of Medicine at Mount Sinai
Categories
Clinical Trial, Fibrosis, Alopecia, Janus Kinase
Funding
Pfizer (United States)